Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy and radiotherapy improved quality of life and reduced symptoms in lung cancer patients.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Breast cancer patients often worry, lose weight, and cope by praying, meditating, or seeking support.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.